Quanome Technologies, Inc.

Quanome Technologies, Inc. (QNME) Stock Analysis

$0.383

+0.046 (+11.96%)At close

Loading chart…
High
0.386
Open
0.360
VWAP
0.38
Volume
159.27K
Mkt Cap
—
Low
0.360
Amount
59.95K
EV/EBITDA, TTM
0.00

Lakeside Holding Limited is a holding company. The Company, through its subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd, is a medical injection and pharmaceutical distributor. It procures products from manufacturers, stores the products at designated warehouses, and distributes them to hospitals, distributors and other healthcare providers, primarily through agents.

AI analysis of Quanome Technologies, Inc. (QNME)

Sell

Given the current price of 0.38, the stock's RSI is at 37.591, indicating it is oversold. However, the forward P/E ratio is 0, and the gross margin has dropped to 7.96%, which raises concerns about profitability. The stock has seen a 20-day change of -48.35%, suggesting significant downward momentum. Therefore, it is advisable to sell rather than buy at this time.

Valuation Metrics

The current forward P/E ratio for Quanome Technologies, Inc. (QNME) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

QNME FAQ — answered by Alphio AI

Lakeside Holding Limited is a holding company. The Company, through its subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd, is a medical injection and pharmaceutical distributor. It procures products from manufacturers, stores the products at designated warehouses, and distributes them to hospitals, distributors and other healthcare providers, primarily through agents.

Given the current price of 0.38, the stock's RSI is at 37.591, indicating it is oversold. However, the forward P/E ratio is 0, and the gross margin has dropped to 7.96%, which raises concerns about profitability. The stock has seen a 20-day change of -48.35%, suggesting significant downward momentum. Therefore, it is advisable to sell rather than buy at this time.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading